Biodesix (BDSX) Share-based Compensation (2019 - 2026)

Biodesix has reported Share-based Compensation for 8 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 14.71% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (down 13.84% YoY), and the FY2025 full-year result was $4.1 million, down 37.65% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $2.6 million in Q1 2024, with the low at $954000.0 in Q3 2023.
• Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $1.2 million in 2022.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 153.8% — and 2025, when it plunged 63.18%.
• Biodesix's Share-based Compensation stood at $2.1 million in 2022, then tumbled by 47.95% to $1.1 million in 2023, then rose by 17.02% to $1.3 million in 2024, then retreated by 15.02% to $1.1 million in 2025, then rose by 3.72% to $1.1 million in 2026.
• The last three Share-based Compensation figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.